A business in context

TRVI research notebook

Read the disclosures. Follow the relationships. Keep the dates in view.

Research JSON

Filing timeline

Download filings CSV

SEC submissions · retrieved 2026-09-08 · 8005 issuers; up to 32 recent company reports and 8 ownership-change filings per issuer

  1. 10-Q · Quarterly report

    Report date 2026-06-30 · 0001193125-26-338023

  2. 8-K · Current report

    Report date 2026-08-06 · 0001193125-26-337974 · Items 2.02,9.01

  3. 4 · Ownership change

    Report date 2026-06-03 · 0001193125-26-257488

  4. 4 · Ownership change

    Report date 2026-06-03 · 0001193125-26-257373

  5. 4 · Ownership change

    Report date 2026-06-03 · 0001193125-26-257371

  6. 4 · Ownership change

    Report date 2026-06-03 · 0001193125-26-257370

  7. 4 · Ownership change

    Report date 2026-06-03 · 0001193125-26-257366

  8. 8-K · Current report

    Report date 2026-06-03 · 0001193125-26-257365 · Items 5.03,5.07,9.01

  9. 10-Q · Quarterly report

    Report date 2026-03-31 · 0001193125-26-206390

  10. 8-K · Current report

    Report date 2026-05-05 · 0001193125-26-206382 · Items 2.02,9.01

  11. DEF 14A · Proxy statement

    Report date 2026-04-21 · 0001193125-26-166695

  12. 8-K · Current report

    Report date 2026-04-16 · 0001193125-26-160355 · Items 1.01,2.02,8.01,9.01

  13. 10-K · Annual report

    Report date 2025-12-31 · 0001193125-26-110783

  14. 8-K · Current report

    Report date 2026-03-17 · 0001193125-26-110767 · Items 2.02,9.01

  15. 8-K · Current report

    Report date 2026-03-09 · 0001193125-26-098676 · Items 8.01

  16. 4 · Ownership change

    Report date 2026-02-19 · 0001193125-26-061399

  17. 4 · Ownership change

    Report date 2026-02-19 · 0001193125-26-061396

  18. 4 · Ownership change

    Report date 2026-02-19 · 0001193125-26-061394

  19. 8-K · Current report

    Report date 2025-12-01 · 0001193125-25-308769 · Items 5.02

  20. 10-Q · Quarterly report

    Report date 2025-09-30 · 0001193125-25-280166

  21. 8-K · Current report

    Report date 2025-11-13 · 0001193125-25-280149 · Items 2.02,9.01

  22. 8-K · Current report

    Report date 2025-08-14 · 0001563880-25-000005 · Items 5.02

  23. 10-Q · Quarterly report

    Report date 2025-06-30 · 0000950170-25-105066

  24. 8-K · Current report

    Report date 2025-08-07 · 0000950170-25-105011 · Items 2.02,9.01

  25. 8-K · Current report

    Report date 2025-06-11 · 0000950170-25-087486 · Items 5.02,5.07,9.01

  26. 8-K · Current report

    Report date 2025-06-03 · 0001193125-25-134913 · Items 1.01,8.01,9.01

  27. 8-K · Current report

    Report date 2025-06-02 · 0001193125-25-133273 · Items 8.01

  28. 8-K · Current report

    Report date 2025-06-02 · 0001193125-25-132890 · Items 8.01

  29. 10-Q · Quarterly report

    Report date 2025-03-31 · 0000950170-25-067011

  30. 8-K · Current report

    Report date 2025-05-08 · 0000950170-25-066971 · Items 2.02,9.01

  31. DEF 14A · Proxy statement

    Report date 2025-04-29 · 0000950170-25-059628

  32. 10-K · Annual report

    Report date 2024-12-31 · 0000950170-25-041194

  33. 8-K · Current report

    Report date 2025-03-18 · 0000950170-25-041187 · Items 2.02,9.01

  34. 8-K · Current report

    Report date 2025-03-10 · 0000950170-25-036503 · Items 8.01

  35. 8-K · Current report

    Report date 2025-01-08 · 0000950170-25-003286 · Items 2.02,8.01,9.01

  36. 8-K · Current report

    Report date 2024-12-15 · 0001193125-24-279715 · Items 1.01,8.01,9.01

  37. 8-K · Current report

    Report date 2024-12-12 · 0000950170-24-135602 · Items 8.01

  38. 8-K · Current report

    Report date 2024-12-03 · 0000950170-24-132883 · Items 8.01

  39. SC 13G/A · Ownership disclosure

    0001104659-24-119338

  40. SC 13G/A · Ownership disclosure

    0001104659-24-117756

Reported insider transactions

Download transactions CSV

SEC insider transactions · retrieved 2026-09-07 · 2026 Q2: filings in this completed quarter; not a live transaction feed

Purchases and sales include open-market or private transactions. Grants, exercises and tax withholding are shown separately. Amendments and joint reports can overlap; rows are not a net-buying score. Prices retain the filing's units; consult its footnotes.

Transaction rows by code · counts, not monetary totals
Purchase: 0 transaction rows0PSale: 0 transaction rows0SGrant / award: 5 transaction rows5AExercise / conversion: 0 transaction rows0MTax / exercise payment: 0 transaction rows0FGift: 0 transaction rows0G
P · PurchaseS · SaleA · Grant / awardM · Exercise / conversionF · Tax / exercise paymentG · Gift

5 matching transaction rows.

Transaction / filedReporting ownerTypeSecuritySharesReported price
2026-06-03
2026-06-04
Mathers Edward TA · Grant / award
Acquired
Nonstatutory Stock Option (right to buy)
Derivative security
35000.00.0
2026-06-03
2026-06-04
Meeker David PA · Grant / award
Acquired
Nonstatutory Stock Option (right to buy)
Derivative security
35000.00.0
2026-06-03
2026-06-04
VANLENT ANNEA · Grant / award
Acquired
Nonstatutory Stock Option (right to buy)
Derivative security
35000.00.0
2026-06-03
2026-06-04
Colangelo DominickA · Grant / award
Acquired
Nonstatutory Stock Option (right to buy)
Derivative security
35000.00.0
2026-06-03
2026-06-04
Heffernan Michael ThomasA · Grant / award
Acquired
Nonstatutory Stock Option (right to buy)
Derivative security
35000.00.0

Identity & relationships

Wikidata structured data · retrieved 2026-09-07 · 1611 unambiguous CIK-linked entities; coverage is incomplete

These are sourced identity and relationship claims, with incomplete coverage. Headquarters locations do not describe sales, assets or operating exposure.

SEC issuer · 0001563880Trevi Therapeutics, Inc.

No parent relationship is available in this import; this is not proof of independence.

No verified LEI join available.

GLEIF legal entity reference data · retrieved 2026-09-07 · 1177 checked identities; 0 unavailable records

Search names and former names

    Revenue in constant purchasing power

    USD revenue expressed in 2026-07 consumer-price dollars. Each annual period uses a CPI-U average weighted by the days in its actual reporting interval. This is a purchasing-power comparison, not a company-specific price or volume measure.

    No USD annual revenue periods with complete CPI coverage are available. Non-USD statements are not converted with U.S. CPI.

    Bureau of Labor Statistics · retrieved 2026-09-08 · 9 selected series; gaps remain missing

    Explore the CPI history ↗